C17.2

Clinical Causes: Genetic mutations that lead to uncontrolled cell growth in the intestinal lining. Chronic inflammatory conditions of the small intestine, such as Crohn’s disease. Lifestyle factors including a diet high in processed or red meats and low in fiber. Exposure to certain carcinogens or toxins. Previous radiation therapy to the abdominal area. Family history of gastrointestinal cancers or hereditary cancer syndromes. Age-related cellular changes, with higher incidence in older adults.

Key Symptoms: Unexplained weight loss and fatigue. Abdominal pain or cramping, often persistent or worsening over time. Changes in bowel habits, such as diarrhea or constipation. Occult or visible blood in the stool leading to anemia. Feeling of fullness or bloating in the abdomen. Nausea or vomiting in advanced cases. Difficulty eating due to discomfort or obstruction.

Diagnosis Path: Diagnosing a malignant neoplasm of the ileum typically involves a combination of medical history, physical examination, and diagnostic tests. These may include: - Imaging studies such as CT scans or MRI to visualize the abdomen and identify tumors. - Endoscopic procedures like capsule endoscopy or enteroscopy to directly view the small intestine. - Biopsy during endoscopy to confirm malignancy. - Blood tests, including complete blood count (CBC) and tumor markers, to assess overall health and disease markers. - Surgical exploration in some cases to obtain tissue samples and evaluate the extent of spread.

Treatment Protocols: Treatment approaches for malignant neoplasm of the ileum depend on factors such as tumor size, location, and stage. Common strategies include: - Surgical removal of the tumor and affected portion of the ileum. - Chemotherapy to target cancer cells that may have spread beyond the primary site. - Radiation therapy, although less common, may be considered in certain cases. - Targeted therapy or immunotherapy as appropriate if specific markers are identified. - Supportive care aimed at managing symptoms and maintaining nutritional health. Early diagnosis and intervention are vital to improve outcomes and reduce the risk of metastasis.